Cotización Dogwood Therapeutics - DWTX

Herramientas de nivel profesional para inversores individuales.

Premium

Último Precio

1.90

Postura de Compra

1.65

Postura de Venta

2.35

Volume Operado de la Acción

143,845

1.62 Rango del Día 3.07

1.85 Rango de 52 semanas 5.29

Precio Anterior

2.97

Precio de Apertura

2.97

Hora

1.7

Última hora de negociación

Volumen promedio (3 m)

117,984

Volumen financiero

US$ 323,127

Precio Promedio Ponderado

2.2464

Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

- IMC-2 treatment, dosed as valacyclovir 750 mg + celecoxib 200 mg twice daily, demonstrated clinically meaningful reduction in Long-COVID related fatigue and sleep disturbance as compared to...

Dogwood Therapeutics Announces Third Quarter 2024 Financial Results

- Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”) formed in October by combination of Virios Therapeutics, Inc. and Pharmagesic (Holdings) Inc., 100% parent company of Wex Pharmaceuticals, Inc. (the...

Dogwood Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Thursday, November 7, 2024

ATLANTA, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Dogwood Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement

ATLANTA, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), formerly Virios Therapeutics, Inc., a clinical‐stage biopharmaceutical company, announced...

Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)

Strategic financing by an affiliate of CK Life Sciences Int’l., (Holdings) Inc., results in working capital of approximately $23 million to fund operations and advance Phase 2b Halneuron®...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-1.86	-49.4680851064	3.76	4.0632	1.85	48285	3.275144	CS
4	-2.05	-51.8987341772	3.95	5.15	1.85	49265	4.14174615	CS
12	-1.65	-46.4788732394	3.55	5.29	1.85	117984	4.02492361	CS
26	-1.65	-46.4788732394	3.55	5.29	1.85	117984	4.02492361	CS
52	-1.65	-46.4788732394	3.55	5.29	1.85	117984	4.02492361	CS
156	-1.65	-46.4788732394	3.55	5.29	1.85	117984	4.02492361	CS
260	-1.65	-46.4788732394	3.55	5.29	1.85	117984	4.02492361	CS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
HCWBHCW Biologics Inc	US$ 1.235 (319.21%)	509.96M
APLMApollomics Inc	US$ 0.1922 (100.42%)	1.67B
SINTSiNtx Technologies Inc	US$ 3.18 (55.88%)	51.86M
ACRSAclaris Therapeutics Inc	US$ 3.16 (54.15%)	30.55M
JWELJowell Global Ltd	US$ 2.8358 (45.43%)	15.45M
QMMMQMMM Holdings Limited	US$ 1.73 (-76.40%)	6.14M
CMAXCareMax Inc	US$ 0.87 (-48.21%)	838.95k
NGNENeurogene Inc	US$ 19.82 (-42.58%)	2M
DWTXDogwood Therapeutics Inc	US$ 1.85 (-37.71%)	143.85k
SGDSafe and Green Development Corporation	US$ 1.68 (-36.84%)	489.76k
APLMApollomics Inc	US$ 0.1922 (100.42%)	1.68B
HCWBHCW Biologics Inc	US$ 1.235 (319.21%)	511.7M
ELABElevai Labs Inc	US$ 0.0225 (1.81%)	290.23M
NVDANVIDIA Corporation	US$ 140.15 (-1.29%)	222.24M
SMCISuper Micro Computer Inc	US$ 21.54 (15.93%)	198.08M